Physician profile
Jonathon Schening
NPI 1588293393
$1,355.27
in general payments reported to CMS, 2019-2025
13 companies · $910 in 2025
The $910 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $194 · 2024: $252 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $332.65 | 2023-2025 | Tezspire, Fasenra, Airsupra |
| Ars Pharmaceuticals Operations, INC. | $247.11 | 2025 | Neffy |
| Blueprint Medicines Corporation | $134.92 | 2024 | Ayvakit |
| Glaxosmithkline, LLC. | $124.98 | 2025 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $121.85 | 2023 | Cuvitru |
| Galderma Laboratories, L.P. | $115.94 | 2025 | Nemluvio |
| Abbvie INC. | $109.01 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $50.14 | 2025 | Dupixent |
| Procept Biorobotics Corporation | $32.68 | 2025 | |
| Genzyme Corporation | $25.55 | 2025 | |
| Pharming Healthcare, INC. | $22.94 | 2023 | Ruconest |
| Grifols USA, LLC | $18.83 | 2025 | Xembify |
| Exact Sciences Corporation | $18.67 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Schening listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.